About PointCross
PointCross is a company based in Foster City (United States) founded in 2000. PointCross has raised $120 thousand across 2 funding rounds. The company has 109 employees as of April 09, 2024. PointCross offers products and services including XBIOM™ Solutions Platform, XBIOM™ VDR, XBIOM™ MDR, XBIOM™ UDM, and eDataValidator. PointCross operates in a competitive market with competitors including Aganitha, Cellumen, Emergentec, Conifer Point and Growdea Technologies, among others.
- Headquarter Foster City, United States
- Employees 109 as on 09 Apr, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pointcross .Com Private Limited
- Date of Incorporation 16 Mar, 2000
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$2.19 M (USD)4.83as on Mar 31, 2023
-
Net Profit
$154.52 K (USD)7.49as on Mar 31, 2023
-
EBITDA
$210.66 K (USD)-7.97as on Mar 31, 2023
-
Total Equity Funding
$120 K (USD)
in 2 rounds
-
Latest Funding Round
$60 K (USD), Seed
Jun 01, 2007
-
Investors
Not available
-
Employee Count
109
as on Apr 09, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PointCross
PointCross offers a comprehensive portfolio of products and services, including XBIOM™ Solutions Platform, XBIOM™ VDR, XBIOM™ MDR, XBIOM™ UDM, and eDataValidator.
Platform for ingesting and curating clinical study data.
Handles exchange of study data from various sources.
Automates transformation and standardization of data.
Provides universal data model for querying and storage.
Ensures compliance and quality in clinical data sets.
Funding Insights of PointCross
PointCross has successfully raised a total of $120K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $60 thousand completed in June 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by PointCross
Investment portfolio details for PointCross
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PointCross
Detailed financials for PointCross
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pointcross Comparisons
Peer comparison for PointCross
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PointCross
PointCross operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aganitha, Cellumen, Emergentec, Conifer Point and Growdea Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of AI-powered drug discovery and development solutions
|
|
| Locked | Locked | Locked |
Systems biology solutions for drug safety and efficacy are provided.
|
|
| Locked | Locked | Locked |
Computational solutions and consulting for better decision making in biomarker, target and drug development.
|
|
| Locked | Locked | Locked |
New drugs are developed using custom fragment-based design software.
|
|
| Locked | Locked | Locked |
Offers AI and machine learning for in-silico drug discovery and bioinformatics services.
|
Detailed competitors of PointCross
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pointcross
Complete news archive for PointCross
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PointCross
PointCross was founded in 2000 and raised its 1st funding round 7 years after it was founded.
PointCross is headquartered in Foster City, United States. It is registered at Foster City, California, United States.
PointCross is a funded company, having raised a total of $120K across 2 funding rounds to date.
As of Apr 09, 2024, the latest employee count at PointCross is 109.
Annual revenue of PointCross is $2.19M as on Mar 31, 2023.
PointCross Life Sciences provides technologies to support drug safety development through a suite of Nonclinical and Clinical offerings These include safety biomarker detection and analytics, data validation, regulatory reviews, submissions support, and study data conversion services. Its clients include global BioPharma companies as well as the FDA. It has developed the Xbiom Platform MySEND software. MySEND is a free, downloadable personal desktop toolbox for nonclinical data sets validation, review, and visualization. It allows the user to view data as tabulations, interactive graphics with charts, or through the advanced histopathology viewers. Xbiom is the big data platform tailored to both nonclinical and clinical industry needs in the areas of research and regulatory submission. It has different versions such as Xbiom Insights Clinical Biomarker, Xbiom Insights Nonclinical, Xbiom Regulatory Clinical Nonclinical.
PointCross's top competitors include Aganitha, Cellumen and Emergentec.
PointCross offers XBIOM™ Solutions Platform, XBIOM™ VDR, XBIOM™ MDR, XBIOM™ UDM, and eDataValidator.